These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 37402371)

  • 21. Genome editing with CRISPR-Cas nucleases, base editors, transposases and prime editors.
    Anzalone AV; Koblan LW; Liu DR
    Nat Biotechnol; 2020 Jul; 38(7):824-844. PubMed ID: 32572269
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypercompact adenine base editors based on transposase B guided by engineered RNA.
    Kim DY; Chung Y; Lee Y; Jeong D; Park KH; Chin HJ; Lee JM; Park S; Ko S; Ko JH; Kim YS
    Nat Chem Biol; 2022 Sep; 18(9):1005-1013. PubMed ID: 35915259
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A 'new lease of life': FnCpf1 possesses DNA cleavage activity for genome editing in human cells.
    Tu M; Lin L; Cheng Y; He X; Sun H; Xie H; Fu J; Liu C; Li J; Chen D; Xi H; Xue D; Liu Q; Zhao J; Gao C; Song Z; Qu J; Gu F
    Nucleic Acids Res; 2017 Nov; 45(19):11295-11304. PubMed ID: 28977650
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The compact Casπ (Cas12l) 'bracelet' provides a unique structural platform for DNA manipulation.
    Sun A; Li CP; Chen Z; Zhang S; Li DY; Yang Y; Li LQ; Zhao Y; Wang K; Li Z; Liu J; Liu S; Wang J; Liu JG
    Cell Res; 2023 Mar; 33(3):229-244. PubMed ID: 36650285
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CRISPR-Cas nucleases and base editors for plant genome editing.
    Gürel F; Zhang Y; Sretenovic S; Qi Y
    aBIOTECH; 2020 Jan; 1(1):74-87. PubMed ID: 36305010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular Basis and Genome Editing Applications of a Compact
    Tang N; Wu Z; Gao Y; Chen W; Wang Z; Su M; Ji W; Ji Q
    ACS Synth Biol; 2024 Jan; 13(1):269-281. PubMed ID: 38061052
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genome editing using the endogenous type I CRISPR-Cas system in
    Hidalgo-Cantabrana C; Goh YJ; Pan M; Sanozky-Dawes R; Barrangou R
    Proc Natl Acad Sci U S A; 2019 Aug; 116(32):15774-15783. PubMed ID: 31341082
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comprehensive assessment of miniature CRISPR-Cas12f nucleases for gene disruption.
    Xin C; Yin J; Yuan S; Ou L; Liu M; Zhang W; Hu J
    Nat Commun; 2022 Sep; 13(1):5623. PubMed ID: 36153319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeted activation of diverse CRISPR-Cas systems for mammalian genome editing via proximal CRISPR targeting.
    Chen F; Ding X; Feng Y; Seebeck T; Jiang Y; Davis GD
    Nat Commun; 2017 Apr; 8():14958. PubMed ID: 28387220
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Programmed genome editing by a miniature CRISPR-Cas12f nuclease.
    Wu Z; Zhang Y; Yu H; Pan D; Wang Y; Wang Y; Li F; Liu C; Nan H; Chen W; Ji Q
    Nat Chem Biol; 2021 Nov; 17(11):1132-1138. PubMed ID: 34475565
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Miniature type V-F CRISPR-Cas nucleases enable targeted DNA modification in cells.
    Bigelyte G; Young JK; Karvelis T; Budre K; Zedaveinyte R; Djukanovic V; Van Ginkel E; Paulraj S; Gasior S; Jones S; Feigenbutz L; Clair GS; Barone P; Bohn J; Acharya A; Zastrow-Hayes G; Henkel-Heinecke S; Silanskas A; Seidel R; Siksnys V
    Nat Commun; 2021 Oct; 12(1):6191. PubMed ID: 34702830
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Precise and heritable genome editing in evolutionarily diverse nematodes using TALENs and CRISPR/Cas9 to engineer insertions and deletions.
    Lo TW; Pickle CS; Lin S; Ralston EJ; Gurling M; Schartner CM; Bian Q; Doudna JA; Meyer BJ
    Genetics; 2013 Oct; 195(2):331-48. PubMed ID: 23934893
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficient CRISPR editing with a hypercompact Cas12f1 and engineered guide RNAs delivered by adeno-associated virus.
    Kim DY; Lee JM; Moon SB; Chin HJ; Park S; Lim Y; Kim D; Koo T; Ko JH; Kim YS
    Nat Biotechnol; 2022 Jan; 40(1):94-102. PubMed ID: 34475560
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovering the Genome-Wide Activity of CRISPR-Cas Nucleases.
    Tsai SQ
    ACS Chem Biol; 2018 Feb; 13(2):305-308. PubMed ID: 29281250
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Closely related type II-C Cas9 orthologs recognize diverse PAMs.
    Wei J; Hou L; Liu J; Wang Z; Gao S; Qi T; Gao S; Sun S; Wang Y
    Elife; 2022 Aug; 11():. PubMed ID: 35959889
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CRISPR-Cpf1-mediated genome editing and gene regulation in human cells.
    Li T; Zhu L; Xiao B; Gong Z; Liao Q; Guo J
    Biotechnol Adv; 2019; 37(1):21-27. PubMed ID: 30399413
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthetic chimeric nucleases function for efficient genome editing.
    Liu RM; Liang LL; Freed E; Chang H; Oh E; Liu ZY; Garst A; Eckert CA; Gill RT
    Nat Commun; 2019 Dec; 10(1):5524. PubMed ID: 31797930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transposon-encoded nucleases use guide RNAs to promote their selfish spread.
    Meers C; Le HC; Pesari SR; Hoffmann FT; Walker MWG; Gezelle J; Tang S; Sternberg SH
    Nature; 2023 Oct; 622(7984):863-871. PubMed ID: 37758954
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diverse Class 2 CRISPR Effectors as Active Nucleases with Expanded Targeting Capabilities.
    Wang M; Rieber L; van Baaren J; Morgan M; Merrett S; McDowell I; Bowen T
    CRISPR J; 2024 Apr; 7(2):120-130. PubMed ID: 38635326
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Engineered Cas12i2 is a versatile high-efficiency platform for therapeutic genome editing.
    McGaw C; Garrity AJ; Munoz GZ; Haswell JR; Sengupta S; Keston-Smith E; Hunnewell P; Ornstein A; Bose M; Wessells Q; Jakimo N; Yan P; Zhang H; Alfonse LE; Ziblat R; Carte JM; Lu WC; Cerchione D; Hilbert B; Sothiselvam S; Yan WX; Cheng DR; Scott DA; DiTommaso T; Chong S
    Nat Commun; 2022 May; 13(1):2833. PubMed ID: 35595757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.